Table 2: Clinical profile of the patients at baseline and treatment history.
Variable | Category | Frequency |
WHO stage | Stage 1 | 398 (33.0) |
Stage 2 | 299 (24.8) | |
Stage 3 | 384 (31.8) | |
Stage 4 | 125 (10.4) | |
TB screening results | No signs/symptoms | 1398 (99.0) |
On treatment | 6 (0.4) | |
Suspected TB | 8 (0.6) | |
Any non-communicable disease | No | 1268 (86.1) |
Yes | 204 (13.9) | |
Regimen type | EFV | 945 (64.2) |
NVP | 527 (35.8) | |
Adherence | Good | 959 (65.2) |
Poor | 513 (34.8) | |
CTX dapsone | Yes | 1472 (100) |
Missed doses | No | 1059 (98.5) |
Yes | 16 (1.5) | |
Delays in taking medication | No | 1054 (98.9) |
Yes | 12 (1.1) |
Presentation of the clinical profile of the patient enrolled for the study at baseline level which most significant thing was screening of TB among patient being enrolled up to 99%.